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Abstract The modulation of a cloned neuronal calcium channel 
was studied in a human embryonic kidney cell line (HEK293). 
The HEK293 cells were stably transfected with the ciiEd cDNA, 
containing the pore forming subunit of a neuronal class E calcium 
channel. Inward currents of 25 ± 1 . 9 pA/pF (« = 79) were 
measured with the cloned ceiEd-subunit. The application of the 
peptide hormone somatostatin, carbachol, ATP or adenosine 
reduced the amplitude of Ca 2 + and Ba 2 + inward currents and 
exhibited a slowing of inactivation. This inhibitory effect by 
somatostatin was significantly impaired after pre-incubating the 
transfected cell line with pertussis toxin (PTX). Internal 
perfusión of the cells with the G-protein-inactivating agent 
GDP-J3-S or with the permanently activating agent GTP-y-S also 
attenuated the somatostatin effect. The inhibition indicates that 
modulation of the ceiEd-mediated Ca 2 + current involves pertussis 
toxin-sensitive G-proteins. The block of Ca 2 + and Ba 2 + inward 
currents by somatostatin is also found in cells expressing a 
truncated aiEd-subunit which lacks a 129-bp fragment in the C-
terminus. This fragment corresponds to the major structural 
difference between two native human CCIE splice variants. As 
somatostatin inhibits inward currents through both, the cloned 
«lEd- and the truncated otiEd DEL-subunit, the hormone-
mediated modulation is independent from the presence of the 
129-bp insertion in the C-terminus. 
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1. Introduction 
In neurons as well as in many non-exitable cells, the stim-
ulation of multiple types of neurotransmitter and hormone 
receptors activates heterotrimeric GTP-binding proteins (G-
proteins) which subsequently influence the activity of volt-
age-gated Ca 2 + channels [1-6]. The regulation of Ca 2 + chan-
nels is crucial as Ca 2 + is one of the main intracellular mes-
sengers that triggers neurotransmitter release, contraction, 
secretion, and gene expression. Voltage-activated Ca 2 + chan-
nels in skeletal muscle, heart and brain exist as heterooligo-
meric proteins composed of at least three different subunits, 
oti, ß, and α2δ. Additional tissue-specific subunits, like a γ-
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subunit, are found e.g. in skeletal muscle (for review, see [7-
10]). 
The α ι -subuni t determines the major biophysical and phar-
macological properties of the channel complex. Molecular 
cloning and expression studies have demonstrated that the 
oei-subunit is sufficient to form functional channels without 
the co-injection or co-transfection of auxiliary subunits [11]. 
The expression of the human OIIB subunit, however, might be 
dependent on auxiliary subunits [12]. 
So far, six different mammalian cti -subunits have been de-
scribed (OCIA to (XIE, and Otis). The oci-subunit of the class E 
(OCIE) has been cloned from human brain [11,13]. Channels 
formed by this type are resistant to common Ca 2 + channel 
blockers and seem to underlie the Ca 2 + currents predomi-
nantly found in cerebellar granule cells [31]. Immunocyto-
chemical staining showed that the otiE-subunit is distributed 
throughout the brain, and it is most prominently expressed in 
deep midline structures, such as caudate-putamen, thalamus, 
hypothalamus, amygdala, cerebellum, and a variety of nuclei 
in the ventral midbrain and brainstem [13-15]. Hormonal 
modulat ion of E type Ca 2 + channel currents has been re-
ported with opposite results [26,28]. The rabbit (XIE-3 -subunit 
is inhibited by somatostatin (SST) [28] while the human ho-
molog is insensitive when expressed in HEK293 cells [26]. In 
this study, we show that E type Ca 2 + channel currents re-
corded from stable transfectants expressing human full-length 
C<IE (c<iEd) or a truncated ctiE-subunit (oiiEd-DEiO in HEK293 
cells are reduced by activation of somatostatin receptors. A 
similar reduction was achieved by stimulating purin-receptors 
and muscarinic receptors. This in vitro hormonal inhibition of 
Ca 2 + inward currents is in accordance with the presence of 
structural motifs for Gßy binding in cloned ociE-subunits (for 
review, [37]). 
2. Materials and methods 
2.1. Construction and transfection of the expression plasmids 
HEK293 cells were transfected with the longer human ΓΧΙΕ splice 
variant [11], defined as oiiEd now. The Smal fragment of the pHBE239 
vector [11] which carried a full-length human oiiEd cDNA was sub-
cloned into the EcoRY site of the pcDNA3 vector (Invitrogen). In 
addition, a second expression plasmid was constructed (= O:IE<I-DEL) in 
which 129 bp of the longer human aiEd splice variant [11] were de-
leted (bp 5896-6024, accession number in Genbank L27745). This 
insertion is not present in the human OIIE-3 splice variant used in 
the study of Toth et al. [26] and represents the major difference be-
tween the two cloned human OCIE splice variants [11,13]. The cDNA of 
ttiEd-DEL in the second expression plasmid was mutated by overlap 
extension using PCR-amplification with appropriate primer [35]. The 
amplified cDNA fragments of aiEd-DEL were completely sequenced. 
The successful deletion of 129 bp was confirmed, and the rest of the 
sequence was found to be identical with the wild-type etna cDNA. 
HEK293 cells were transfected using standard calcium-phosphate 
precipitation technique (Stratagene Kit). Positive cell clones were iso-
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lated after growth in the presence of geneticin (1 mg/ml) and cloning 
by limiting dilution. 
2.2. Culture of the HEK293 cells 
The stably transfected HEK293 cells were grown in DMEM sup-
plemented with 15% fetal calf serum, non-essential amino acids, anti-
biotics (penicillin, 50 IU/ml, streptomycin, 50 mg/ml, and geneticin, 
1 mg/ml). 
2.3. Electrophysiological recordings 
Ca2+ and Ba2+ currents were measured using the whole-cell variant 
of the patch-clamp method [33] at 37°C. For data aquisition, an 
Axoclamp 2000 amplifier (Axon Instruments, USA) connected to a 
PC equipped with the ISO-2 acquisition package (Friedrich, Cologne, 
Germany) was used. 
Prior to recording, cells were rinsed in normal Tyrode's solution. 
The coverslip with the cells was transferred to the recording chamber 
which was warmed to 37°C. All drugs were applied using a rapid 
perfusión system consisting of a multibarrelled ejection pipette. The 
cells were continuously superfused by standard extracellular solution 
or by the drug-containing solution. The extracellular solution con-
tained (in mM): CaCl2 or BaCl2 15, NMG 154, MgCl2 1, glucose 
5, HEPES 10. The pH was adjusted to 7.4. The patch pipettes were 
filled with an internal solution containing (in mM): CsCl 112, MgCl2 
1, HEPES 5, MgATP 1, EGTA 10 (pH 7.4). Part of the experiments 
were carried out using the perforated-patch method with amphoter-
icin-B added to the pipette solution. 
Recordings were filtered at 3 kHz using a 4-pole Bessel-filter and 
digitized at 40 kHz. Holding potentials of —80 mV were used to 
record ionic current data throughout the study. Steady-state inactiva-
tion of ionic currents were measured by 2-s pre-pulses and applying 
the depolarizing protocol from the same membrane potential (—80 
mV) each time. Recordings were capacity corrected. From the holding 
potential, 4 scaled hyperpolarizing pre-pulses were given and the sum 
of the pre-pulses was subtracted from each recording. 
2.4. Materials 
Tissue culture media, sera and other supplements were from 
GIBCO (Eggenstein, Germany). Pertussis toxin and cholera toxin 
were obtained from RBI (Biotrend Chemikalien, Cologne, Germany). 
Guanosine 5'-0-(2-thiodiphosphate) (GDP-ß-S); guanosine-5'-0-(3-
thiotriphosphate)(GTP-y-S) and all other substances were of the high-
est grade and purchased from Sigma (Deisenhofen, Germany). A con-
centrated stock solution (30 mg/ml) of amphotericine-B was made up 
in DMSO and diluted to the final concentration of 450 μg/ml in the 
pipette solution. 
2.5. Data analysis 
Statistical analysis and curve-fitting were carried out using the ISO-
2 software package, Origin (Microcal, Northampton, MA), or Sigma-
Plot (Jandel). All grouped data are reported as mean ± S.E.M. 
3. Results 
3.1. Characterization of αγΕα ««d otiEd-DEL channels expressed 
in HEK293 cells 
During the time period of our measurements (within 2-4 
days after trypsin-dissociation and plating), untransfected 
HEK293 cells did not express any significant voltage-depend-
ent Ca2+ channel currents (see also [16]). The HEK293 cell 
clone expressing the ociEd-subunits developed current densities 
between 10 and 70 pA/pF with a mean of 25 ±1.9 pA/pF 
(n = 79). 
In stably transfected HEK293 cells, Ca2+ currents could be 
elicited in Ca2+ (Fig. 1A) or Ba2+-containing solution (Fig. 
IB). As a typical high-voltage-activated channel [11], the aiEd 
channel shows an activation curve similar to L-type Ca2+ 
channels. The channels activated at about —30 mV and max-
imal currents were elicited at +20 mV in Ca2+-containing 
solution (Fig. 2). Inactivation occurred at rather negative 
holding potentials (Fig. 2C). The midpoint of the steady-state 
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inactivation curve was calculated as —40 mV. With Ba2+ in-
stead of Ca2+ as charge carrier, the current-voltage curve was 
shifted by 10 mV to more negative potentials potentials (Fig. 
1C). However, kinetics of the Ba2+ currents were not different 
from the currents carried by Ca2+ (Fig. 1A). This suggests 
that the fast inactivation of the currents is not related to a 
Ca2+-induced inactivation as it is seen with the L-type Ca2+ 
channels. 
A second cell clone, which stably expressed the shorter 
«íEd-DEL subunit (see Section 2), showed identical basic bio-
physical properties as the aiEd-expressing cells. The mean 
current density of these HEK-ociEd-DEL cells was 16 ±6 pA/ 
pF in = 6). 
3.2. Somatostatin inhibition of Ca2+ currents 
SST is known to inhibit the Ca2+ influx through voltage-
dependent Ca2+ channels in various neuronal [17] and neuro-
endocrine cells [18]. HEK293 cells endogenously express SST 
receptors of the subtype SSTR2 [19,20]. Application of SST to 
«íEd-transfected HEK293 cells produced a rapid, reversible 
and concentration-dependent reduction in the magnitude of 
the Ca2+ and Ba2+ currents (Fig. 3). A concentration that 
induced a consistent maximal inhibitory effect, i.e. 1 μΜ 
SST, was used throughout all experiments (Fig. 3A). In 
some experiments, desensitization was observed after 20-30 
s of SST application (Fig. 7B). 
The SST-induced reduction of the Ca2+ and Ba2+ current 
amplitude was voltage-dependent. The Ca2+ current ampli-
tude was reduced over the voltage range —10 to +40 mV 
with the greatest reduction occurring at the maximal ampli-
tude (at +20 mV, Fig. 4A). Application of 1 μΜ SST led to a 
reduction of 50 ±3.5% (» = 25) when 15 mM Ca2+ in the ex-
tracellular solution was present as charge carrier. In 15 mM 
Ba2+ solution, the SST effect on the peak current was less 
(37 ±4.6%, w = 6). 
The kinetics of the currents were not significantly changed 
by 1 μΜ SST. The time to peak was unaltered (Fig. 4B) and 
in the presence of SST the inactivating phase of the current 
was not significantly slower with time constant τ of 18 ±0.6 
and 19 ±0.8 ms, » = 45, for control and SST, respectively, 
each in 15 mM Ca2+. The current voltage relation and the 
inactivation characteristics during SST application were al-
most identical with those under control conditions (Fig. 
4A,C). 
No SST-induced reduction of the Ca2+ current amplitude 
was reported for the shorter human CCIE splice variant [26]. To 
investigate the hypothesis that the additional 129-bp insertion 
in (XiEd (Fig. 5A) might be responsible for the contrary results, 
the 129-bp (bp 5896-6024 [11]) sequence was deleted [35]. The 
SST-mediated inhibition was also found in cell lines express-
ing the oiiEd-DEL-subunit (Fig. 5B). In 23 experiments with the 
deletion mutants, 6 cells did not react to SST, 2 showed a 
weak stimulation and in 15 cells Ca2+ inward current was 
blocked by 1 μΜ SST. The percentage of inhibition was 
30 ± 17% («=15) showing a higher degree of variation as in 
the otiEd-expressing HEK293 cells. The fast decay of inhibi-
tion could be mediated by a faster desensitization or by other 
unknown processes (Fig. 5B). As both cell lines expressing 
cciEd or aiEd-DEL, respectively, are reacting to SST, other fac-
tors must cause the observed differences with respect to SST 
modulation of human cCiE-subunits. A G-protein-binding site 
has been identified (Fig. 5C) in the I—II loop of all three non-
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Fig. 1. Voltage-activated calcium currents in HEK293 cells expressing the aiEd-subunit. A,B: examples of currents, elicited from holding poten-
tial —80 mV with pulses as indicated. Traces of currents in solution containing 15 mM Ba2+ (A) or Ca2+ (B). C: current-voltage relation of 
the peak currents in Ba2+ or Ca2+. 
L-type Ca2+ channel ai-subunits [27] which supports the idea 
that at least the longer [11] and the truncated human ociEd-
subunit are sensitive towards a SST-mediated inhibition of 
Ca2+ inward currents after expression in HEK293 cells. 
3.3. Inactivation of G-proteins by pertussis toxin (PTX) or 
cholera toxin (CTX) 
It has been shown that SST-receptors act via G-proteins 
[18,21]. To investigate whether G-proteins are involved in 
this regulation of the cciEd channels, HEK293 cells were in-
cubated with PTX (1 mg/ml) for 12 h to inactivate the PTX-
sensitive G¡- and G0-proteins. The mean Ca
2+ current density 
was not changed by PTX incubation (25.6 ±2.2 pA/pF, 
«=15). The SST-induced inhibition of the peak current, how-
ever, was reduced to 37.6 ±3.9% (»=11), compared to 50% 
without PTX, suggesting that part of the effect of SST is due 
to the activation of a PTX-sensitive G-protein. The incubation 
of the cells with CTX (12 h, 1 or 2 mg/ml) to inactivate Gs-
proteins did not affect the reduction of the peak currents 
caused by SST. The mean reduction induced by 1 μΜ SST 
on the CTX-treated cells was 54 ±2.9% («=10) in solution 
containing 15 mM Ca2+. 
3.4. G-protein activation or inactivation by GTP-γ-Ξ and 
GDP-ß-S 
To corroborate the role of G-proteins in the signal cascade 
leading to a reduction of the Ca2+ current, we added stable 
GTP analogs to the pipette solution to directly activate or 
inactivate G-proteins. The inactivation of all heterotrimeric 
G-proteins by GDP-ß-S did not change the currents under 
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control conditions. The SST-induced reduction of the current 
was in some cases almost totally blocked. On average, the 
peak current was reduced only by 22.7 ±3.8% («=11) after 
GDP-ß-S treatment. 
To irreversibly activate the G-proteins, we applied the non-
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Fig. 3. Suppression of the peak currents by somatostatin. A: currents elicited in 15 mM Ca2+ were suppressed by SST in different concentra-
tions. The duration of each SST application was 20 s. B: suppression of the currents in 15 mM Ba2+ by 1 μΜ SST. The duration of the SST 
application is indicated by bars. 
effect might result from the gradual activation of G-proteins 
due to a gradual equilibration between the GTP-y-S within the 
pipette solution and the cytoplasm. If SST was applied after 
the equilibration period, we observed a much smaller reduc-
tion in the peak Ca2+ currents compared to the control meas-
urements. The mean SST-induced current reduction under the 
influence of GTP-y-S was only 24.7 ±5% (M = 7). 
These results clearly show that about one-half of the SST-
induced depression of the Ca2+ inward current is mediated 
through a G-protein-dependent pathway. 
3.5. Reduction of the currents by carbachol, adenosine and 
ATP 
To see whether the modulation of cciEd channels could be 
Fig. 2. Characterization of the calcium currents in the HEK293 cells expressing the (XiEd-subunits. A: current-voltage relation of the peak cur-
rents. Mean of 14 normalized curves. B: conductance curve. The conductance (G) was calculated according to G(V) = I(V)I(V— VmY) where I(V) 
is the peak Zea as a function of the test potential, Frev is the reversal potential for /ca- The data were fitted by a Boltzmann function: Gl 
Gmax= l/{l+exp[—(VteBt— Vos)lk]}, where V0& is the half-maximal activation and k the slope factor. K0.5 was estimated as 3.6±0.27 mV and 
A: = 7.8 ±0.24. C: Steady state activation and steady state inactivation. The steady state inactivation was determined by examining the amplitude 
of the current elicited by a test pulse to 10 mV after prepulses to various potentials. Averaged normalized current amplitudes (n= 12) were plot-
ted as a function of the prepulse potential. The data were fitted by a Boltzmann function. ///maX = //{l+exp[(Fh0id—K0.5)/fc]}. F0.5 was estimated 
as -40 ± 0.2 mV, k = 8.5 ± 0.28 for the inactivation, and for the activation F0.5 was -3.8 ± 1 mV, k = 6.2 ± 1. 
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Fig. 4. Effects of somatostatm (1 μΜ) on calcium currents. A: current voltage relation under control condition and after application of SST. 
B: original traces of currents elicited by test pulses to +10 mV. In the lower part the SST current was scaled up to the peak value of the con-
trol current. C: steady-state inactivation curves under control condition and after application of SST. The fitted curves were done according to 
the Boltzmann equation (see Fig. 2). The half-maximal inactivation F0.5 was estimated as —34 ±0.5 mV in the control and -32 ±0.2 mV in 
the presence 1 μΜ SST. 
achieved by other receptors than the SST receptor, we used 
carbachol to stimulate muscarinic acetylcholine receptors, 
ATP and adenosine the agonists of purinoceptors. In a similar 
manner as SST, carbachol produced an inhibition of the Ca2+ 
or Ba2+ inward currents (Fig. 7A). With carbachol (1 μΜ), a 
reduction of 54 ±7% (in 15 mM Ba2+, n-6) was achieved. 
Both, ATP and adenosine, also decreased the Ca2+ and Ba2+ 
currents (Fig. 7B,C). 
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Fig. 5. Inhibition of voltage-induced Ca2+ currents by somatostatin (1 μΜ) in an aiEd deletion mutant. A: using appropriate primer, a 129-bp 
fragment was deleted from the cloned human aiEd cDNA [11]. The deleted fragment is absent in otiE-3 [13], another cloned human otiE splice 
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common Gßy-binding motif, QXXER, with other G-protein effectors. This motif is localized in the I—II loop at the Ca2+ channel ß-subunit in-
teraction domain. The end of transmembrane domain IS6 and the region with the homologous sequences (see beyond Gßy) are marked. 
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4. Discussion 
The physiological role of the recently cloned voltage-acti-
vated calcium channel otiEd subtype is not clear at all. No 
selective blockers are known, therefore, it is advantagous if 
the channels are investigated in an environment devoid of 
other channel types which might interfere. This can be 
achieved with some restrictions by expressing the cloned chan-
nel subunits in oocytes or in cultured mammalian cells. The 
HEK293 cell line we used expresses very low levels of endog-
enous voltage-dependent Ca2+ channels (<0 .2 pA/pF; see 
also [16]). Thus, it was unnecessary to use blockers or special 
voltage protocols to inactivate interfering channel types as it 
was the case in a previous study using GH3 cells [28]. 
The ctiEd channels expressed in transfected HEK293 cells 
show high current densities which are 100-fold higher than 
reported for endogenous currents [16]. They have electrophys-
iological properties similar to those previously described in an 
oocyte-expressing system [11,29]. (i) Peak currents were higher 
than seen with other 0C1 -subunits and somewhat higher in 
equimolar Ca2+ concentrations than in Ba2+. (ii) The kinetics 
were not different in Ca2+ or Ba2+. (iii) The fast inactivation 
of the currents was not dependent on the presence of Ca2+. 
Unlike L-type Ca2+ channels, the CXIE type does not possess a 
functional Ca2+-binding motif [30]. (iv) The steady-state in-
activation curves gave values in the same range. 
The modulation of the activity of voltage-dependent Ca2+ 
channels is an important mechanism by which many hor-
mones, growth factors and neuromodulators exert their ac-
tion. Thus, in addition to their dependency on the transmem-
brane voltage, Ca2+ channels are regulated by second 
messengers, phosphorylation, G-proteins and Ca2+ itself and 
of course by combinations of these. The peptide hormone 
SST, which was described originally as an inhibitor of growth 
hormone secretion, acts as a neurotransmitter and neuromod-
ulator within the central nervous system. SST receptors couple 
to distinct cellular effector systems, including adenylyl cyclase, 
K+ and Ca2+ channels [22,23]. In various cell types, the SST 
receptors are often linked to the different effector systems by 
G-proteins. For example, pertussis toxin-sensitive G-proteins 
of the Go type selectively couple SST receptors to Ca2+ chan-
nels [24]. Here, we have demonstrated that SST decreases 
Ca2+ currents elicited in otiEd-transfected HEK293 cells, and 
that the decrease is in part mediated by a PTX-sensitive G-
protein. 
It has been shown previously that a cloned somatostatin 
receptor expressed in CHO cells preferentially associates 
with Giot3 and GoK2 [20]. HEK293 cells express endogenously 
Gi and Gq and somatostatin receptor subtype SSTR2 ,but no 
Go [19], and the SST receptor associates with Gia3. It is un-
likely that cAMP mediates the effect of SST on Ca2+ currents 
because only the SSTR3 subtype-activating Giai is function-
ally linked to adenylyl cyclase [20]. Similarly, in calcitonin-
secreting cells [25] SST inhibition of the calcitonin secretion 
occurs via suppression of voltage-dependent Ca2+ channel 
currents by a PTX-sensitive mechanism but independent of 
the cAMP concentration. 
One important finding is that HEK293 cells can be used to 
investigate interactions between hormone receptors and their 
effects on G-proteins and ion channels. HEK293 cells express 
various types of receptors on their surface. They express Ga-
subunits of all four major families (a¡, as, aq, and O43) [26]. 
We could demonstrate effects of SST, carbachol, adenosine 
and ATP on the human ociEd-subunit. In vitro studies show 
that direct binding between recombinant GßiY2 and oci-sub-
units from dihydropyridine-insensitive Ca2+ channels, like 
«iA, « IB , and CCIE, is possible [27]. A proposed interaction 
site is conserved only in the non-L-type Ca2+ channel «i-sub-
units (see Fig. 5C), and it should be expected that Gßy-sub-
units mediate SST interaction with otiE-subunits, too. The 
present study shows that the human ociEd-subunit is modu-
lated by endogenous hormone receptors of HEK293 cells 
which are known to interact via Gßy-subunits. This modula-
tion is not impaired in the truncated oiiEd-DEL-subunit which 
G. Mehrke et al.lFEBS Letters 408 (1997) 261-270 269 
A 
< 
Q . 
C 
CD 
cn 
CD 
Q . 
-300-, 
-400-
-500 
-600 
-700 
-800 
-900 
carbachol 
~60~ 120 180 240 300 
B 
-100-, 
-200-
< 
a. 
¡ ■ 
c CD 
3 
CJ 
J¿ 
cc 
CD 
Q. 
-300 
-400 
-500 
-600 
SST SST adenosine 
Λν·«* 
A V 
60 120 180 240 300 360 420 480 
< 
Q . 
-200 
-300 
c 
CD 
O 
Cü 
S -400 
ATP SST 
V ^ \ . 
~60 120 180 240 300 360 420 480 
time (s) 
Fig. 7. Reduction of the voltage-induced Ca2+ currents by carbachol, SST, ATP, and adenosine. A: decrease of the peak currents by superfu-
sion with 10 μΜ carbachol. B: first two applications of 1 μΜ SST showing a desensitization effect, then an application of 2 μΜ adenosine. 
C: application of 1 μΜ ATP followed by 1 μΜ SST. 
270 G. Mehrke et al.lFEBS Letters 408 (1997) 261-270 
shows that the truncated 129 bp of the C-terminus, which 
differ in two human CXIE splice variants [11,26], are not crucial 
for the hormone-mediated interaction investigated in our 
study. A similar hormonal modulation is seen in the shorter 
rabbit αΐΕ-3-subunit [28]. 
The expression of the shorter cloned human OCIE-3 variant 
[13] expressed in HEK293 or COS-7 cells did not lead to SST-
sensitive C a 2 + currents when co-transfected with ßiß- and 
a2Ö-subunits [26,38]. This could be due either to the different 
OCIE splice variant used or to the fact that co-expressed Ca 2 + 
channel ß-subunits interfere with the G-protein-mediated in-
hibition by competing for the same binding site at the CCIE-
subunit [34]. In this case, it should be expected that the kind 
of ß-subunit used and the level of expression of ß achieved 
might influence the degree of OCIE inhibition by SST and other 
hormones. Preliminary results with co-expressed ß3 still reveal 
hormone sensitivity for aiEd (Pereverzev, Mehrke, Hescheler 
and Schneider, unpublished results) while ß2a blocks opioid 
sensitivity even in the longer OCIE splice variant [39]. Future 
experiments should elucidate these hormononal interactions in 
the presence of an in vivo co-expressed ß-subunit in more 
detail. 
In the ceiB-subunit, additional G-protein interaction sites 
are proposed for the C-terminus [36]. Interestingly, one addi-
tional Q X X E R consensus site for the binding of Gßy is lo-
cated in the C-terminus only of human OC1E-3-, oiiEd-, and 
aiEd-DEL-subunit. 
In vivo, R type Ca 2 + currents may be carried at least in part 
by ociE-containing Ca 2 + channels [31]. In rat hippocampal 
neurons, SST inhibits a resistant component of high-voltage-
activated Ca 2 + currents which is seen after applying the 
known blockers of other Ca 2 + channel types. The remaining 
rest component , which is sensitive to 200 μ Μ C d 2 + , represents 
13% of the whole high-voltage-activated Ca 2 + current [32]. 
This indicates that in vivo R type Ca 2 + currents with a similar 
SST sensitivity are present which might be mimicked in our 
expression system. In future, additional studies have to be 
performed in native systems to elucidate the in vivo function 
of these hormone-modulated R type Ca 2 + currents. 
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